GMAB News Today: Stay Updated with the Latest Genmab A/S News in Real Time
Find GMAB news now at Meyka AI. Stay informed with the latest{" "} Genmab A/S stocks updates, including price news, market analysis, and expert insights.
GMAB●NASDAQ
HealthcareBiotechnology
$24.73
$0.85(3.56%)
U.S. Market opens in 16h 3m
Advertisement
📅 24 days ago
GMAB Maintained at Buy by Deutsche Bank, May 2026
Deutsche Bank maintains GMAB at Buy rating with price target lowered to DKK 2,250 from DKK 2,400.
Read more 12
📅 29 days ago
GMAB Earnings Preview: Genmab Q1 2026 on May 7
Genmab (GMAB) reports Q1 2026 earnings May 7. Analysts expect $0.15 EPS, $905.77M revenue. Stock at $27.52.
Read more 12
📅 3 months ago
BNTX Stock Today: Founders to Exit; PT Cut to $167 – March 12
BNTX stock today: founders to exit by 2026 and Clear Street cuts price target to $167. What this means for leadership, IP, valuation, mRNA pipeline, and key trading levels for German investors.
Read more 12
📅 9 months ago
BNTX News Today: BioNTech Stock Rises Sharply on Promising mRNA Flu-V3
BioNTech shares surge with promising interim results from its mRNA-based flu vaccine trial, signaling potential beyond COVID-19.
Read more 12